Market Access Professional: Which One Are You?
Market access isn’t what it used to be. Not too long ago, it was seen as the last step—something that happened after approval. Today? It’s at the center of how therapies reach patients, shape healthcare systems, and deliver value. And…
Role of HEOR in Accelerated Drug Approvals
Health Economics and Outcomes Research (HEOR) plays a crucial role in ensuring that therapies approved under expedited regulatory pathways demonstrate not only clinical benefit but also real-world value. Programs such as the FDA’s Accelerated Approval Program, Breakthrough Therapy Designation, and…
Unmasking Bias in HEOR: How Hidden Errors Impact RWE
Bias in HEOR or RWE (Real-world evidence ) refers to systematic errors that can distort findings, leading to incorrect conclusions about healthcare interventions, costs, or patient outcomes. Bias can occur at various stages, from study design to data collection, analysis, and…
What is HEOR? Guide to Health Economics and Outcomes Research
You’ve probably heard the buzzwords “healthcare” and “research” thrown around a lot, but have you ever encountered the mysterious acronym “HEOR”? Well, buckle up, because we’re about to decode this scientific-sounding term and sprinkle in some humor along the way.…
Using Artificial Intelligence in Health Economics and Outcomes Research
Artificial Intelligence (AI): is the simulation of human intelligence activities by robots/machines/ technologies, especially computer systems Health Economics and Outcomes Research HEOR: Read this HEOR post AI can play a crucial role to strengthen healthcare systems from disease prediction to…
NICE released a real-world evidence framework
On June 23rd the UK’s National Institute for Health and Care Excellence (NICE) released a real-world evidence (RWE) framework as part of its five-year (2021-2026) strategic plan. the framework is intended to be a “living document” which will develop over…
